Comparison of new patients with bence-jones, igg and iga myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria

B. Sirohi, R. Powles, S. Kulkarni, C. Rudin, R. Saso, R. Lal, S. Singhal, J. Mehta, C. Horton, J. Treleaven

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint Dive into the research topics of 'Comparison of new patients with bence-jones, igg and iga myeloma receiving sequential therapy: The need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria'. Together they form a unique fingerprint.

Medicine & Life Sciences